Omar Moinuddin, MD
University of Michigan
Kellogg Eye Institute
Project Title: Metabolic Activation to Prevent Photoreceptor Cell Death in a Preclinical Model of Macular Degeneration
Dr. Moinuddin is embarking on his first year as a postdoctoral fellow at the University of Michigan, Kellogg Eye Center in Ann Arbor, Michigan, after graduating from Oakland University William Beaumont School of Medicine in Rochester, Michigan. Moinuddin’s long-term research focus is the development of a comprehensive understanding of the pathophysiology and treatment of ophthalmic disease.
Early in medical school, Moinuddin designed and conducted a longitudinal capstone research project with the Cytogenomics Laboratory at Oakland University William Beaumont School of Medicine, studying the differential therapeutic response in multiple myeloma patients with t(11:14) (q13:q32) translocation and subsequent IGH gene deletion. During the clinical years of his medical school training, research motivations principally focused on ophthalmology as he conducted research at Associated Retinal Consultants in Royal Oak, Michigan under Dr. George Williams, an internationally recognized vitreoretinal surgeon and leader in the field of academic ophthalmology. Research topics ranged from studying fellow eye outcomes in patients with neovascular age-related macular degeneration to investigating surgical outcomes using a novel 3D heads-up surgical display.
During his year as a Callahan Scholar, Dr. Moinuddin will investigate the strategy of reprogramming cellular metabolism as a novel therapeutic approach for photoreceptor neuroprotection during age-related macular degeneration.